Kymera Therapeutics (KYMR) EPS (Basic) (2019 - 2026)
Kymera Therapeutics' (KYMR) quarterly EPS (Basic) came in at -$0.71 in Q1 2026, up 13.25% year-on-year from -$0.63 in Q1 2025, and up 31.05% on a QoQ basis from -$1.03 in Q4 2025.
Kymera Therapeutics (KYMR) EPS (Basic) (2019 - 2026) Analysis & Trends
Kymera Therapeutics (KYMR) has 8 years of EPS (Basic) data on file, last reported at -$0.71 in Q1 2026.
- On a quarterly basis, EPS (Basic) rose 13.25% year-over-year to -$0.71 in Q1 2026; TTM through Mar 2026 was -$3.23, a 7.46% decrease from a year earlier, with the FY2025 full-year figure at -$3.69, down 23.53% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.71, up from -$1.03 in the prior quarter.
- Over the last five years, EPS (Basic) for KYMR reached as high as -$0.25 in Q4 2023 and fell as low as -$3.26 in Q1 2022.
- Historically, EPS (Basic) has averaged -$0.91 across 5 years, with a median of -$0.79 in 2022.
- On a YoY basis, EPS (Basic) climbed as much as 85.2% in 2022 and fell as far as 1013.93% in 2022.
- Year by year, EPS (Basic) stood at -$0.65 in 2022, then surged by 61.92% to -$0.25 in 2023, then tumbled by 282.99% to -$0.94 in 2024, then decreased by 9.19% to -$1.03 in 2025, then surged by 31.05% to -$0.71 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$0.71 in Q1 2026, -$1.03 in Q4 2025, and -$0.94 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Kymera Therapeutics | 10.77 Bn | 10.12 Bn | - | -0.71 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.71 |
| Dec 31, 2025 | -1.03 |
| Sep 30, 2025 | -0.94 |
| Jun 30, 2025 | -0.95 |
| Mar 31, 2025 | -0.82 |
| Dec 31, 2024 | -0.94 |
| Sep 30, 2024 | -0.82 |
| Jun 30, 2024 | -0.58 |
| Mar 31, 2024 | -0.69 |
| Dec 31, 2023 | -0.25 |
| Sep 30, 2023 | -0.90 |
| Jun 30, 2023 | -0.67 |
| Mar 31, 2023 | -0.70 |
| Dec 31, 2022 | -0.65 |
| Sep 30, 2022 | -0.79 |
| Jun 30, 2022 | -0.78 |
| Mar 31, 2022 | -3.26 |
| Dec 31, 2021 | -0.71 |
| Sep 30, 2021 | -5.33 |
| Jun 30, 2021 | -0.55 |